Premna microphylla Turcz pectin-modified diosmetin nanoparticles: A galectin-3 targeting strategy for precise colitis intervention
- 15 July 2025
- journal article
- Published by Elsevier in Carbohydrate Polymers
- Vol. 368 (Pt 1) , 124067
Abstract
No abstract availableKeywords
Funding Information
- Intelligence Community Postdoctoral Research Fellowship Program (GZC20241090)
- Shenzhen Science and Technology Innovation Program (ZDSYS20220117155800001)
This publication has 42 references indexed in Scilit:
- Diosmetin as a promising natural therapeutic agent: In vivo, in vitro mechanisms, and clinical studiesPhytotherapy Research, 2024
- Resveratrol‐loaded pH‐responsive Mesona chinensis polysaccharides‐zein nanoparticles for effective treatment of ulcerative colitisJournal of the Science of Food and Agriculture, 2024
- An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel diseaseActa Biomaterialia, 2023
- Oral Metal‐Free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD)Small, 2023
- Galectins: An Ancient Family of Carbohydrate Binding Proteins with Modern Functions2022
- Pectic Galactan Polysaccharide‐Based Gene Delivery System for Targeting NeuroinflammationAdvanced Functional Materials, 2021
- Quercetin Attenuates Atherosclerotic Inflammation by Inhibiting Galectin‐3‐NLRP3 Signaling PathwayMolecular Nutrition & Food Research, 2021
- Galectin-3 type-C self-association on neutrophil surfaces; The carbohydrate recognition domain regulates cell functionJournal of Leukocyte Biology, 2018
- Pectin nanocoating reduces proinflammatory fibroblast response to bacteriaJournal of Biomedical Materials Research Part A, 2017
- Optimizing conventional therapies for inflammatory bowel diseaseCurrent Gastroenterology Reports, 2009